Bosnia included in EU plans to procure Remdesivir

Bosnia and Herzegovina, which Europe’s Joint Procurement Agreement, is included in plans to procure Remdesivir, an antiviral medication developed by the biopharmaceutical company Gilead Sciences which may be effective for COVID-19 treatment, the Ministry of Civil Affairs told N1 on Tuesday. Pročitaj više